3 | SEC Filings Hub

Filing metadata

Accession number: 0000921895-24-001663
Form type: Form 3
Filer: 4D Molecular Therapeutics, Inc.
CIK: CIK 1650648
Filed: Aug 01, 2024
Reporting period: Jul 22, 2024
Description: Initial ownership

Documents

0000921895-24-001663-index.htm

Complete submission

0000921895-24-001663.txt

directory listing

Filed by

4D Molecular Therapeutics, Inc.